Trials / Completed
CompletedNCT02279511
ATP in Alzheimer Disease
Evaluating the Effectiveness of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in Patients With Moderate Alzheimer's Disease and Severe: Double-blind Dose Finding Clinical Trial.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Sara Varea · Academic / Other
- Sex
- All
- Age
- 55 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
To Check whether systemic treatment with ATP alters the profile of cerebral metabolism in patients with Alzheimer's disease using MRS techniques (Magnetic Resonance Spectroscopy) and adjust the infusion (minimum effective dose) that promotes this metabolic change.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ADENOSINE TRIPHOSPHATE | Infusion of 2.5g of ATP in 500 mL of saline solution. (IV) |
| DRUG | PLACEBO | Infusion of 500 mL of saline solution. (IV) |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2014-10-31
- Last updated
- 2017-03-29
Locations
2 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02279511. Inclusion in this directory is not an endorsement.